Ricardo Pasquini
Overview
Explore the profile of Ricardo Pasquini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
3179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Azambuja A, Mion A, Schluga Y, Beltrame M, Senegaglia A, Funke V, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076750
Monitoring measurable residual disease (MRD) is critical for the management of B-cell acute lymphoblastic leukemia (B-ALL). While a quantitative assessment of BCR::ABL1 transcripts is standard for Philadelphia chromosome-positive cases (Ph+...
2.
de Azambuja A, Beltrame M, Malvezzi M, Schluga Y, Justus J, Lima A, et al.
Sci Rep
. 2025 Feb;
15(1):6942.
PMID: 40011589
Minimal residual disease (MRD) detected before hematopoietic cell transplantation (HCT) is associated with adverse outcomes in patients with high-risk acute leukemia. However, the ideal time points for post-transplant MRD assessment...
3.
Rodrigues A, Fernandes J, Gregianin L, Nichele S, Trennepohl J, Muratori R, et al.
Bone Marrow Transplant
. 2025 Jan;
PMID: 39865157
Hematopoietic stem cell transplantation (HSCT) is an established treatment for selected patients with inborn errors of metabolism. In this first report from the PDWP-SBTMO, we included 105 patients transplanted between...
4.
Loth G, Dumke C, Muratori R, Pelegrina P, Peixoto C, Bach J, et al.
Br J Haematol
. 2024 Oct;
205(6):2387-2402.
PMID: 39462810
Aplastic anaemia in infants and young children presents unique challenges due to high prevalence of inherited bone marrow failure syndromes (IBMFS) in this age group. The objective of this study...
5.
Medeiros G, Funke V, Lima A, Mion A, Menezes I, Setubal D, et al.
Transplant Cell Ther
. 2024 Mar;
30(6):597.e1-597.e8.
PMID: 38522578
Tyrosine kinase inhibitors (TKIs) have revolutionized therapy for patients with chronic myeloid leukemia (CML) over the last two decades. However, some patients still do not achieve an adequate response to...
6.
Nichele S, Bonfim C, Junior L, Loth G, Kuwahara C, Trennephol J, et al.
Eur J Haematol
. 2023 Jun;
111(3):423-431.
PMID: 37259830
Background: Telomere biology diseases (TBD) result from defective telomere maintenance, leading to bone marrow failure. The only curative treatment for aplastic anemia related to TBD is a hematopoietic cell transplant...
7.
Lima A, Getz J, do Amaral G, Loth G, Funke V, Nabhan S, et al.
Transplant Cell Ther
. 2023 May;
29(8):493.e1-493.e10.
PMID: 37220839
Graft failure (GF) is one of the major concerns after allogeneic hematopoietic cell transplantation (allo-HCT) and remains a significant cause of morbidity and mortality. Although previous reports have associated the...
8.
Gutierrez-Rodrigues F, Munger E, Ma X, Groarke E, Tang Y, Patel B, et al.
Blood
. 2022 Dec;
141(17):2100-2113.
PMID: 36542832
The choice to postpone treatment while awaiting genetic testing can result in significant delay in definitive therapies in patients with severe pancytopenia. Conversely, the misdiagnosis of inherited bone marrow failure...
9.
Pillonetto D, Piovezan B, Nichele S, Lima A, Pasquini R, Pereira N, et al.
Int J Lab Hematol
. 2022 Nov;
45(1):82-89.
PMID: 36333938
Introduction: This study proposed to identify Fanconi anemia (FA) mutations in Brazilian patients and to investigate their impact on clinical manifestations and malignancies onset. Methods: A total of 116 patients...
10.
Lima A, Bonfim C, Getz J, do Amaral G, Petterle R, Loth G, et al.
Transplant Cell Ther
. 2022 Jul;
28(10):698.e1-698.e11.
PMID: 35882362
Donor-specific HLA antibodies (DSAs) have been recognized as a major risk factor for graft failure (GF) in adult patients with malignancies undergoing haploidentical transplantation with post-transplantation cyclophosphamide (haplo-PTCy). However, the...